Cardiology最新文献

筛选
英文 中文
Mismatch in Cardiomyopathy. 心肌病的错配。
IF 1.9 4区 医学
Cardiology Pub Date : 2024-01-01 Epub Date: 2023-12-23 DOI: 10.1159/000535922
Rainer Ebid
{"title":"Mismatch in Cardiomyopathy.","authors":"Rainer Ebid","doi":"10.1159/000535922","DOIUrl":"10.1159/000535922","url":null,"abstract":"","PeriodicalId":9391,"journal":{"name":"Cardiology","volume":" ","pages":"248-249"},"PeriodicalIF":1.9,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139032181","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Inotropes in Advanced Heart Failure: The Last Tool in the Box of Failures? 晚期心力衰竭患者的肌注:失败箱中的最后工具?
IF 1.9 4区 医学
Cardiology Pub Date : 2024-01-01 Epub Date: 2024-05-23 DOI: 10.1159/000538994
Lamis Haider, Nathan Mewton
{"title":"Inotropes in Advanced Heart Failure: The Last Tool in the Box of Failures?","authors":"Lamis Haider, Nathan Mewton","doi":"10.1159/000538994","DOIUrl":"10.1159/000538994","url":null,"abstract":"","PeriodicalId":9391,"journal":{"name":"Cardiology","volume":" ","pages":"438-439"},"PeriodicalIF":1.9,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141086861","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Anticoagulation Intensity during Appendage Occlusion: Lessons from Silent Cerebral Embolism. 阑尾闭塞期间的抗凝强度:无声脑栓塞的启示。
IF 1.9 4区 医学
Cardiology Pub Date : 2024-01-01 Epub Date: 2024-02-14 DOI: 10.1159/000537708
Kexin Wang, Mingjia Xu, Zhe Wang, Zidun Wang, Mingfang Li, Hailei Liu, Hongwu Chen, Weizhu Ju, Minglong Chen
{"title":"Anticoagulation Intensity during Appendage Occlusion: Lessons from Silent Cerebral Embolism.","authors":"Kexin Wang, Mingjia Xu, Zhe Wang, Zidun Wang, Mingfang Li, Hailei Liu, Hongwu Chen, Weizhu Ju, Minglong Chen","doi":"10.1159/000537708","DOIUrl":"10.1159/000537708","url":null,"abstract":"<p><strong>Introduction: </strong>Endovascular left atrial appendage occlusion (LAAO) is associated with a high incidence of peri-procedure silent cerebral embolism (SCE), while the recommended activated clotting time (ACT) level by the expert consensus is lower than that in atrial fibrillation (AF) ablation. The aim of our study was to investigate whether raising the targeted ACT level during LAAO to the same level as AF ablation could decrease the incidence of SCE.</p><p><strong>Methods: </strong>It was a prospective observational cohort study. Consecutive AF patients receiving LAAO between January 2021 and December 2022 were included and categorized into two groups based on the time of enrollment. Patients enrolled in 2021 (group 250) maintained a target ACT level of ≥250 s during LAAO procedure, while patients enrolled in 2022 (group 300) maintained the peri-procedure ACT ≥300 s. All patients underwent cerebral magnetic resonance imaging before and after the procedure.</p><p><strong>Results: </strong>A total of 81 patients were included (38 in the group 250 and 43 in the group 300). After inverse probability of treatment weighting (IPTW), patients in the group 250 showed a significantly lower incidence of SCE than group 300 (IPTW p = 0.038). Only a stable high ACT pattern could decrease the risk of SCE. No significant differences were found between other ACT change patterns on the SCE incidence.</p><p><strong>Conclusion: </strong>Raising the peri-procedure ACT level to a stable 300 s could decrease the risk of the SCE without increasing the major bleeding events.</p>","PeriodicalId":9391,"journal":{"name":"Cardiology","volume":" ","pages":"349-356"},"PeriodicalIF":1.9,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11309060/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139734549","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The Balance of CD8-Positive T Cells and PD-L1 Expression in the Myocardium Predicts Prognosis in Lymphocytic Fulminant Myocarditis. 心肌中CD8阳性T细胞和PD-L1表达的平衡可预测淋巴细胞性暴发性心肌炎的预后。
IF 1.9 4区 医学
Cardiology Pub Date : 2024-01-01 Epub Date: 2023-10-12 DOI: 10.1159/000534518
Hiroaki Hiraiwa, Ryota Morimoto, Yuta Tsuyuki, Kaori Ushida, Ryota Ito, Shingo Kazama, Yuki Kimura, Takashi Araki, Takashi Mizutani, Hideo Oishi, Tasuku Kuwayama, Toru Kondo, Takahiro Okumura, Toyoaki Murohara
{"title":"The Balance of CD8-Positive T Cells and PD-L1 Expression in the Myocardium Predicts Prognosis in Lymphocytic Fulminant Myocarditis.","authors":"Hiroaki Hiraiwa, Ryota Morimoto, Yuta Tsuyuki, Kaori Ushida, Ryota Ito, Shingo Kazama, Yuki Kimura, Takashi Araki, Takashi Mizutani, Hideo Oishi, Tasuku Kuwayama, Toru Kondo, Takahiro Okumura, Toyoaki Murohara","doi":"10.1159/000534518","DOIUrl":"10.1159/000534518","url":null,"abstract":"<p><strong>Introduction: </strong>The clinical significance and prognostic value of T cell involvement and programmed cell death-1 (PD-1)/programmed cell death ligand-1 (PD-L1) have not been established in lymphocytic fulminant myocarditis (FM). We investigated the prognostic impact of the number of CD4+, CD8+, FoxP3+, and PD-1+ T cells, as well as PD-L1 expression, in cardiomyocytes in lymphocytic FM.</p><p><strong>Methods: </strong>This is a single-center observational cohort study. Myocardial tissue was obtained from 16 consecutive patients at lymphocytic FM onset. The median follow-up was 140 days. Cardiac events were defined as a composite of cardiac death and left ventricular-assist device implantation. CD4, CD8, FoxP3, PD-1, and PD-L1 immunostaining were performed on myocardial specimens.</p><p><strong>Results: </strong>The median age of the patients was 52 years (seven men and nine women). There was no significant difference in the number of CD4+ cells. The number of CD8+ cells and the CD8+/CD4+ T cell ratio were higher in the cardiac event group (Event+) than in the group without cardiac events (Event-) (p = 0.048 and p = 0.022, respectively). The number of FoxP3+ T cells was higher in the Event+ group (p = 0.049). Although there was no difference in the number of PD-1+ cells, cardiomyocyte PD-L1 expression was higher in the Event+ group (p = 0.112). Event-free survival was worse in the group with a high CD8+ cell count (p = 0.012) and high PD-L1 expression (p = 0.049). When divided into three groups based on the number of CD8+ cells and PD-L1 expression (CD8highPD-L1high [n = 8], CD8lowPD-L1high [n = 1], and CD8lowPD-L1low [n = 7]), the CD8highPD-L1high group demonstrated the worst event-free survival, while the CD8lowPD-L1high group had a favorable prognosis without cardiac events (p = 0.041).</p><p><strong>Conclusion: </strong>High myocardial expression of CD8+ T cells and PD-L1 may predict a poor prognosis in lymphocytic FM.</p>","PeriodicalId":9391,"journal":{"name":"Cardiology","volume":" ","pages":"28-39"},"PeriodicalIF":1.9,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10836849/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41192051","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Erratum. 勘误表。
IF 1.9 4区 医学
Cardiology Pub Date : 2024-01-01 Epub Date: 2023-10-23 DOI: 10.1159/000534442
{"title":"Erratum.","authors":"","doi":"10.1159/000534442","DOIUrl":"10.1159/000534442","url":null,"abstract":"","PeriodicalId":9391,"journal":{"name":"Cardiology","volume":" ","pages":"93"},"PeriodicalIF":1.9,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"49688802","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Predictive Value of the Hb/RDW Ratio for the Risk of All-Cause Death in Patients with Heart Failure with Different Ejection Fractions. 不同射血分数心衰患者 HB/RDW 比值对全因死亡风险的预测价值。
IF 1.9 4区 医学
Cardiology Pub Date : 2024-01-01 Epub Date: 2024-01-23 DOI: 10.1159/000536440
Jing Zhou, Wenfang Ma, Yu Wan, Yanji Zhou, Wen Wan, Wenyi Gu, Hongxia Li, Chenggong Xu, Lixing Chen
{"title":"Predictive Value of the Hb/RDW Ratio for the Risk of All-Cause Death in Patients with Heart Failure with Different Ejection Fractions.","authors":"Jing Zhou, Wenfang Ma, Yu Wan, Yanji Zhou, Wen Wan, Wenyi Gu, Hongxia Li, Chenggong Xu, Lixing Chen","doi":"10.1159/000536440","DOIUrl":"10.1159/000536440","url":null,"abstract":"<p><strong>Introduction: </strong>The prognostic value of the ratio of haemoglobin to red cell distribution width (HRR) in different types of heart failure (HF) is not well known.</p><p><strong>Method and results: </strong>We analysed the long-term prognostic value of HRR in patients with HF using the Cox proportional risk model and Kaplan-Meier method. We reviewed consecutive 972 HF patients. The overall mortality rate was 45.68%. Mortality was 52.22% in the HFrEF group and 40.99% in the HFpEF + HFmrEF group. Cox regression showed that when HRR increased by 1 unit, the risk of all-cause death in all HF patients decreased by 22.8% (HR: 0.772, 95% CI: 0.724, 0.823, p &lt; 0.001), in the HFpEF + HFmrEF group it decreased by 15.5% (HR: 0.845, 95% CI: 0.774, 0.923, p &lt; 0.001), and in the HFrEF group it decreased by 36.1% (HR: 0.639, 95% CI: 0.576, 0.709, p &lt; 0.0001). Subgroup analysis showed that there were interactions between the EF and HRR groups. The group in which HRR best predicted all-cause death from HF was group 1 (EF &lt;40%, HRR &lt;9.45), followed by group 2 (EF &lt;40%, HRR ≥9.45), and group 3 (EF ≥40%, HRR &lt;9.45). HRR had no predictive value in group 4 (EF ≥40%, HRR ≥9.45).</p><p><strong>Conclusion: </strong>HRR is an important predictor of all-cause mortality in patients with HF, especially HFrEF. There is an interaction between HRR group and LVEF group.</p>","PeriodicalId":9391,"journal":{"name":"Cardiology","volume":" ","pages":"237-247"},"PeriodicalIF":1.9,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11152022/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139541918","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Prognostic Value of Left Ventricular Global Longitudinal Strain for Major Adverse Cardiovascular Events in Patients with Aortic Valve Disease: A Meta-Analysis. 主动脉瓣疾病患者左心室整体纵向应变对主要不良心血管事件的预后价值:一项荟萃分析。
IF 1.9 4区 医学
Cardiology Pub Date : 2024-01-01 Epub Date: 2024-02-01 DOI: 10.1159/000536331
Hongsheng Liao, Siyuan Yang, Shaomei Yu, Xuanyi Hu, XiongWei Meng, Kui Wu
{"title":"Prognostic Value of Left Ventricular Global Longitudinal Strain for Major Adverse Cardiovascular Events in Patients with Aortic Valve Disease: A Meta-Analysis.","authors":"Hongsheng Liao, Siyuan Yang, Shaomei Yu, Xuanyi Hu, XiongWei Meng, Kui Wu","doi":"10.1159/000536331","DOIUrl":"10.1159/000536331","url":null,"abstract":"<p><strong>Introduction: </strong>Valvular heart disease is one of the most common heart diseases. It is characterized by abnormal function or structure of the heart valves. There may be no clinical symptoms in the early stages. Clinical symptoms of arrhythmia, heart failure, or thromboembolic events may occur in the late stages of the disease, such as palpitation after activities, breathing difficulties, fatigue, and so on. Aortic valve disease is a major part of valvular heart disease. The main treatment for aortic valve disease is valve replacement or repair surgery, but it is extremely risky. Therefore, a rigorous prognostic assessment is extremely important for patients with aortic valve disease. The global longitudinal strain is an index that describes the deformation capacity of myocardium. There is evidence that it provides a test for systolic dysfunction other than LVEF (left ventricular ejection fraction) and provides additional prognostic information.</p><p><strong>Method: </strong>Search literature published between 2010 and 2023 on relevant platforms and contain the following keywords: \"Aortic valve disease,\" \"Aortic stenosis,\" \"Aortic regurgitation,\" and \"longitudinal strain\" or \"strain.\" The data is then extracted and collated for analysis.</p><p><strong>Results: </strong>A total of 15 articles were included. The total population involved in this study was 3,678 individuals. The absolute value of LVGLS was higher in the no-MACE group than in the MACE group in patients with aortic stenosis (Z = 8.10, p &lt; 0.00001), and impaired LVGLS was a risk factor for MACE in patients with aortic stenosis (HR = 1.14, p &lt; 0.00001, 95% CI: 1.08-1.20). There was also a correlation between impaired LVGLS and aortic valve surgery in patients with aortic valve disease (HR = 1.16, p &lt; 0.0001, 95% CI: 1.08-1.25) or patients with aortic valve regurgitation (HR = 1.21, p = 0.0004, 95% CI: 1.09-1.34). We also found that impaired LVGLS had no significant association between LVGLS and mortality during the period of follow-up in patients with aortic valve stenosis (HR = 1.08, 95% CI: 0.94-1.25, p = 0.28), but it was associated with mortality in studies of prospective analyses (HR = 1.34, 95% CI: 1.02-1.75, p = 0.04).</p><p><strong>Conclusions: </strong>Impaired LVGLS correlates with major adverse cardiovascular events in patients with aortic valve disease, and it has predictive value for the prognosis of patients with aortic valve disease.</p>","PeriodicalId":9391,"journal":{"name":"Cardiology","volume":" ","pages":"277-285"},"PeriodicalIF":1.9,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139671321","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Positive Cardiac Biomarkers without Obstructive Coronary Artery Disease: A Confirmed Harbinger of Risk. 无阻塞性冠状动脉疾病的阳性心脏生物标志物:风险的确凿预兆。
IF 1.9 4区 医学
Cardiology Pub Date : 2024-01-01 Epub Date: 2023-12-13 DOI: 10.1159/000535522
Josiah Brown, Sahrai Saeed
{"title":"Positive Cardiac Biomarkers without Obstructive Coronary Artery Disease: A Confirmed Harbinger of Risk.","authors":"Josiah Brown, Sahrai Saeed","doi":"10.1159/000535522","DOIUrl":"10.1159/000535522","url":null,"abstract":"","PeriodicalId":9391,"journal":{"name":"Cardiology","volume":" ","pages":"264-265"},"PeriodicalIF":1.9,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11152008/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138797171","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The Role of Multiple Mutations in Hypertrophic Cardiomyopathy - A New Universe to Discover: Proof of Guiltiness of the Genetic Burden in Worsening Hypertrophic Cardiomyopathy Natural History. 多重突变在肥厚型心肌病中的作用--有待发现的新宇宙:证明遗传负担在肥厚型心肌病自然病史恶化中的作用。
IF 1.9 4区 医学
Cardiology Pub Date : 2024-01-01 Epub Date: 2024-06-14 DOI: 10.1159/000539360
Giuseppe Galati, Olga Germanova, Roberto Franco Enrico Pedretti
{"title":"The Role of Multiple Mutations in Hypertrophic Cardiomyopathy - A New Universe to Discover: Proof of Guiltiness of the Genetic Burden in Worsening Hypertrophic Cardiomyopathy Natural History.","authors":"Giuseppe Galati, Olga Germanova, Roberto Franco Enrico Pedretti","doi":"10.1159/000539360","DOIUrl":"10.1159/000539360","url":null,"abstract":"","PeriodicalId":9391,"journal":{"name":"Cardiology","volume":" ","pages":"451-454"},"PeriodicalIF":1.9,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141330402","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
New Horizons in the Management of Dyslipidemias. 血脂异常管理的新视野。
IF 1.9 4区 医学
Cardiology Pub Date : 2024-01-01 Epub Date: 2024-01-30 DOI: 10.1159/000535878
Walter F Riesen
{"title":"New Horizons in the Management of Dyslipidemias.","authors":"Walter F Riesen","doi":"10.1159/000535878","DOIUrl":"10.1159/000535878","url":null,"abstract":"","PeriodicalId":9391,"journal":{"name":"Cardiology","volume":" ","pages":"590-591"},"PeriodicalIF":1.9,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139641642","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信